MIRA logo

MIRAMira Pharmaceuticals Inc

$0.96
$0.0202
(2.06%)
Today
Closed $0.96
$0.03
(3.13%)
After Hours
Updated: 07:59 PM EDT
Mkt Cap$41.19M
Vol53,496.00
News
all
press releases
What's Going On With MIRA Pharma Stock Tuesday?
MIRA Pharmaceuticals (NASDAQ: MIRA) eyes IND submission for Mira-55 after new 2026 data confirms no CNS side effects.read more...
Benzinga
News Placeholder
More News
News Placeholder
Short Interest in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Drops By 13.9%
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) saw a significant decrease in short interest in February. As of February 27th, there was short interest totaling 489,206 shares, a decrease...
MarketBeat
News Placeholder
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Up 29.4% in February
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 13th, there was short interest totaling...
MarketBeat
News Placeholder
MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 6.6% - Time to Sell?
MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Down 6.6% - Time to Sell...
MarketBeat
News Placeholder
MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Price Down 6.6% - Time to Sell?
MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Price Down 6.6% - What's Next...
MarketBeat
News Placeholder
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Sees Significant Growth in Short Interest
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling...
MarketBeat
News Placeholder
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Update
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 15th, there was short interest totaling...
MarketBeat
News Placeholder
MIRA Pharmaceuticals (NASDAQ:MIRA) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen downgraded shares of MIRA Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat
News Placeholder
Mira Pharmaceuticals Stock Soars 70% After-Hours As Pain Drug Outperforms Morphine; Retail Sees ‘Blockbuster Drug’ In The Making
The company said its oral treatment fully normalized pain and sharply reduced inflammation in preclinical studies, outperforming injected morphine.
Stocktwits
News Placeholder
MIRA Pharma Stock Soars To 2-Month High On $60M SKNY Deal: Retail Sentiment Strong
Retail sentiment on Stocktwits surged, with users expressing optimism about the merger’s success, despite a pullback in after-hours trading.
Stocktwits
<
1
2
...
>

Advertisement|Remove ads.